Highlights
NASDAQ: SNGX       Soligenix Inc
Last Price Today's Change   Day's Range   Trading Volume
2.09   +0.04 (1.95%)  2.08 - 2.27  857,700

Overview

 
Avg Volume (4 weeks):325,355
4 Weeks Range:1.30 - 2.27
4 Weeks Price Volatility (%):
81.44%
52 Weeks Range:0.65 - 2.27
52 Weeks Price Volatility (%):
88.89%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics business segment is developing a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma whereas the Vaccines/BioDefense business segment includes development programs for RiVax, a ricin toxin vaccine candidate; OrbeShield, a GI acute radiation syndrome therapeutic candidate; and SGX943, a melioidosis therapeutic candidate.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers